UNITED THERAPEUTICS Corp (UTHR) › Cash & EquivalentsUNITED THERAPEUTICS Corp (UTHR) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2007-12-31: $139.32M2008-12-31: $129.45M2009-12-31: $100.35M2010-12-31: $252.16M2011-12-31: $168.04M2012-12-31: $159.40M2013-12-31: $284.30M2014-12-31: $397.70M2015-12-31: $831.80M2016-12-31: $1.02B2017-12-31: $705.10M2018-12-31: $669.20M2019-12-31: $738.40M2020-12-31: $738.70M2021-12-31: $894.80M2022-12-31: $961.20M2023-12-31: $1.21B2024-12-31: $1.70B2025-12-31: $1.56B$1.56B2007-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$1.56B-8.3%2026-02-25Balance as of period end2024-12-31$1.70B+40.5%2026-02-25Balance as of period end2023-12-31$1.21B+25.6%2025-02-26Balance as of period end2022-12-31$961.20M+7.4%2024-02-21Balance as of period end2021-12-31$894.80M+21.1%2023-02-22Balance as of period end2020-12-31$738.70M+0.0%2022-02-24Balance as of period end2019-12-31$738.40M+10.3%2021-02-24Balance as of period end2018-12-31$669.20M-5.1%2020-02-26Balance as of period end2017-12-31$705.10M-31.1%2020-02-26Balance as of period end2016-12-31$1.02B+23.0%2020-02-26Balance as of period end2015-12-31$831.80M+109.2%2019-02-27Balance as of period end2014-12-31$397.70M+39.9%2018-02-21Balance as of period end2013-12-31$284.30M+78.4%2017-02-22Balance as of period end2012-12-31$159.40M-5.1%2016-02-25Balance as of period end2011-12-31$168.04M-33.4%2015-02-24Balance as of period end2010-12-31$252.16M+151.3%2014-02-25Balance as of period end2009-12-31$100.35M-22.5%2013-02-26Balance as of period end2008-12-31$129.45M-7.1%2012-02-28Balance as of period end2007-12-31$139.32M—2011-02-24Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)